# Problem Specification

> Grounding: abstract-only. Problem framing is restricted to the metadata and abstract.

## Observations

### O01: ADOD burden analysis and prediction in Asia is presented as lacking
- **Statement**: The abstract states that there is a lack of analysis and prediction of the disease burden of Alzheimer's disease and other dementias in Asia.
- **Evidence**: `metadata.md` abstract Background.
- **Implication**: The study positions Asia-specific burden quantification and forecasting as the central need.

### O02: The study uses GBD 2021 data over 1990-2021
- **Statement**: Data on ADOD in Asia from 1990 to 2021 were collected from the Global Burden of Disease Study 2021.
- **Evidence**: `metadata.md` abstract Design.
- **Implication**: The study is a secondary epidemiological analysis of a standardized global burden database.

### O03: Multiple burden indicators increased from 1990 to 2021
- **Statement**: Deaths, DALYs, incidence, and prevalence increased in Asia from 1990 to 2021.
- **Evidence**: `metadata.md` abstract Results.
- **Implication**: The abstract indicates a broad rise across mortality, morbidity, and occurrence measures rather than a single isolated metric.

### O04: Risk factor patterns differ by risk and sex
- **Statement**: The abstract reports high fasting blood glucose as the top risk factor, with females more susceptible to high BMI and males more likely affected by smoking.
- **Evidence**: `metadata.md` abstract Results.
- **Implication**: Risk-factor intervention plans may need to account for sex-differentiated patterns.

## Gaps

### G01: Full methods and model diagnostics are unavailable
- **Statement**: The abstract names GBD 2021, Joinpoint regression, AAPCs, and ARIMA but does not provide model orders, joinpoint settings, uncertainty intervals, software, or diagnostics.
- **Caused by**: O02.
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

### G02: Country-level detailed burden estimates are unavailable
- **Statement**: The abstract identifies some countries with greatest changes or highest ASMR but does not provide full country-level estimates, denominators, uncertainty intervals, or ranking tables.
- **Caused by**: O03.
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

### G03: Causal interpretation of risk factors is not supported by abstract alone
- **Statement**: The abstract reports risk-factor associations or attributable burden patterns but does not expose causal design, adjustment variables, or comparative risk assessment details.
- **Caused by**: O04.
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

## Key Insight

- **Insight**: Combining GBD 2021 burden measures, Joinpoint/AAPC trend analysis, risk-factor stratification, and ARIMA forecasting can frame ADOD in Asia as both a historical burden increase and a future planning problem.
- **Derived from**: O01, O02, O03, O04.
- **Enables**: A public-health interpretation focused on population aging, risk-factor intervention, and action planning for rising ADOD incidence.

## Assumptions

- A1: GBD 2021 estimates are treated as the analytic source of record in the abstract.
- A2: The abstract's term "Asia" follows the geographical coverage used by the GBD data extraction, but country inclusion rules are not available from provided input.
- A3: Forecast conclusions depend on the ARIMA model named in the abstract; model specification and validation are not available from provided input.
